Search research articles
Contact Us
Filters
Showing results (1-10 of 137) with videos related to
Page
of 14
Sort By:
Epidemiologic Reviews
|
July 1, 2008
Population-based cohort studies on premorbid cognitive function in schizophrenia
James H Maccabe
British Medical Bulletin
|
May 10, 2015
Antipsychotic medication in schizophrenia: a review
John Lally, James H MacCabe
Annals of Hematology
|
August 21, 2020
Clozapine-induced agranulocytosis
Aleksandar Mijovic, James H MacCabe
Therapeutic Advances in Psychopharmacology
|
July 17, 2019
The relationship between nicotine and psychosis
Harriet Quigley, James H MacCabe
Nordic Journal of Psychiatry
|
October 24, 2018
Constipation, ileus and medication use during clozapine treatment in patients with schizophrenia in Iceland
Oddur Ingimarsson, James H MacCabe, Engilbert Sigurdsson
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
August 30, 2019
Stratified medicine in schizophrenia: how accurate would a test of drug response need to be to achieve cost-effective improvements in quality of life?
Huajie Jin, Paul McCrone, James H MacCabe
Cognitive Neuropsychiatry
|
July 28, 2009
Epigenetics, genomic mutations and cognitive function
Abraham Reichenberg, Jonathan Mill, James H MacCabe
Schizophrenia Bulletin
|
August 23, 2011
How genes and environmental factors determine the different neurodevelopmental trajectories of schizophrenia and bipolar disorder
Arsime Demjaha, James H MacCabe, Robin M Murray
The Cochrane Database of Systematic Reviews
|
June 10, 2016
Pharmacological interventions for clozapine-induced sinus tachycardia
John Lally, Mary J Docherty, James H MacCabe
Psychological Medicine
|
February 19, 2021
Demographic and clinical variables associated with response to clozapine in schizophrenia: a systematic review and meta-analysis
Kira Griffiths, Edward Millgate, Alice Egerton, et al.
Page
of 14
Search research articles
Search
Showing results (1-10 of 137) with videos related to
Sort By:
Page
of 14
Epidemiologic Reviews
|
July 1, 2008
Population-based cohort studies on premorbid cognitive function in schizophrenia
James H Maccabe
British Medical Bulletin
|
May 10, 2015
Antipsychotic medication in schizophrenia: a review
John Lally, James H MacCabe
Annals of Hematology
|
August 21, 2020
Clozapine-induced agranulocytosis
Aleksandar Mijovic, James H MacCabe
Therapeutic Advances in Psychopharmacology
|
July 17, 2019
The relationship between nicotine and psychosis
Harriet Quigley, James H MacCabe
Nordic Journal of Psychiatry
|
October 24, 2018
Constipation, ileus and medication use during clozapine treatment in patients with schizophrenia in Iceland
Oddur Ingimarsson, James H MacCabe, Engilbert Sigurdsson
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
August 30, 2019
Stratified medicine in schizophrenia: how accurate would a test of drug response need to be to achieve cost-effective improvements in quality of life?
Huajie Jin, Paul McCrone, James H MacCabe
Cognitive Neuropsychiatry
|
July 28, 2009
Epigenetics, genomic mutations and cognitive function
Abraham Reichenberg, Jonathan Mill, James H MacCabe
Schizophrenia Bulletin
|
August 23, 2011
How genes and environmental factors determine the different neurodevelopmental trajectories of schizophrenia and bipolar disorder
Arsime Demjaha, James H MacCabe, Robin M Murray
The Cochrane Database of Systematic Reviews
|
June 10, 2016
Pharmacological interventions for clozapine-induced sinus tachycardia
John Lally, Mary J Docherty, James H MacCabe
Psychological Medicine
|
February 19, 2021
Demographic and clinical variables associated with response to clozapine in schizophrenia: a systematic review and meta-analysis
Kira Griffiths, Edward Millgate, Alice Egerton, et al.
Page
of 14